Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors

It has been indicated that proton pump inhibitor (PPI) use is associated with a loss of the anti-fracture efficacy of alendronate (AD). However, there are few prospective studies that have investigated the efficacy of AD on lumbar bone mineral density (BMD) in osteoporotic patients who are using PPI...

Descripción completa

Detalles Bibliográficos
Autores principales: Asaoka, Daisuke, Nagahara, Akihito, Hojo, Mariko, Matsumoto, Kenshi, Ueyama, Hiroya, Matsumoto, Kohei, Izumi, Kentaro, Takeda, Tsutomu, Komori, Hiroyuki, Akazawa, Yoichi, Shimada, Yuji, Osada, Taro, Watanabe, Sumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950806/
https://www.ncbi.nlm.nih.gov/pubmed/27446535
http://dx.doi.org/10.3892/br.2016.710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950806/
https://www.ncbi.nlm.nih.gov/pubmed/27446535
http://dx.doi.org/10.3892/br.2016.710

Ejemplares similares